AI-Driven Structural Mapping of Reversible LSD1 Inhibitors

Advanced co-folding models like AlphaFold3 are revolutionizing the discovery of reversible LSD1 inhibitors. By mapping unexplored chemical spaces and identifying novel scaffolds with nanomolar potency, this research provides a high-resolution atlas for rational drug design in oncology and beyond.